Retraction Note: Transient cytokine treatment induces acinar cell reprogramming and regenerates functional beta cell mass in diabetic mice.

Journal

Nature biotechnology
ISSN: 1546-1696
Titre abrégé: Nat Biotechnol
Pays: United States
ID NLM: 9604648

Informations de publication

Date de publication:
03 2020
Historique:
pubmed: 19 2 2020
medline: 19 2 2020
entrez: 19 2 2020
Statut: ppublish

Résumé

This article has been retracted; see accompanying Retraction Note, which can be accessed via a link at the top of the paper.

Identifiants

DOI: 10.1038/s41587-020-0426-2 PMID: 32066957 PMC: PMC7175803
pubmed: 32066957
doi: 10.1038/s41587-020-0426-2
pii: 10.1038/s41587-020-0426-2
pmc: PMC7175803
mid: NIHMS1580560
doi:

Types de publication

Journal Article Retraction of Publication

Langues

eng

Sous-ensembles de citation

IM

Pagination

374

Commentaires et corrections

Type : RetractionOf

Auteurs

Luc Baeyens (L)

Diabetes Research Center, Vrije Universiteit Brussel, Brussels, Belgium.
Diabetes Center, California Institute for Regenerative Medicine (CIRM), University of California San Francisco, San Francisco, California, USA.

Marie Lemper (M)

Diabetes Research Center, Vrije Universiteit Brussel, Brussels, Belgium.

Gunter Leuckx (G)

Diabetes Research Center, Vrije Universiteit Brussel, Brussels, Belgium.

Sofie De Groef (S)

Diabetes Research Center, Vrije Universiteit Brussel, Brussels, Belgium.

Paola Bonfanti (P)

Diabetes Research Center, Vrije Universiteit Brussel, Brussels, Belgium.

Geert Stangé (G)

Diabetes Research Center, Vrije Universiteit Brussel, Brussels, Belgium.

Ruth Shemer (R)

The Institute for Medical Research Israel-Canada, The Hebrew University, Jerusalem, Israel.

Christoffer Nord (C)

Umeå Center for Molecular Medicine, Umeå University, Umeå, Sweden.

David W Scheel (DW)

Diabetes Center, California Institute for Regenerative Medicine (CIRM), University of California San Francisco, San Francisco, California, USA.

Fong C Pan (FC)

Department of Cell and Developmental Biology, Vanderbilt University Program in Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Ulf Ahlgren (U)

Umeå Center for Molecular Medicine, Umeå University, Umeå, Sweden.

Guoqiang Gu (G)

Department of Cell and Developmental Biology, Vanderbilt University Program in Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Doris A Stoffers (DA)

Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.

Yuval Dor (Y)

The Institute for Medical Research Israel-Canada, The Hebrew University, Jerusalem, Israel.

Jorge Ferrer (J)

Institut d'Investigacions Biomediques August Pi i Sunyer, Hospital Clinic de Barcelona, Barcelona, Spain.
Imperial College London, London, UK.

Gerard Gradwohl (G)

Development and Stem Cells Program, Institute of Genetics and Molecular and Cellular Biology (IGBMC), Illkirch, France.

Christopher V E Wright (CVE)

Department of Cell and Developmental Biology, Vanderbilt University Program in Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Mark Van de Casteele (M)

Diabetes Research Center, Vrije Universiteit Brussel, Brussels, Belgium.

Michael S German (MS)

Diabetes Center, California Institute for Regenerative Medicine (CIRM), University of California San Francisco, San Francisco, California, USA.

Luc Bouwens (L)

Diabetes Research Center, Vrije Universiteit Brussel, Brussels, Belgium. lucbo@expa.vub.ac.be.

Harry Heimberg (H)

Diabetes Research Center, Vrije Universiteit Brussel, Brussels, Belgium. Harry.Heimberg@vub.ac.be.

Classifications MeSH